Search results
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 6 hours agoNovavax (NVAX 0.20%) stock has both soared and plummeted at times in recent years. Investors...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 hours agoWhich of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by YCharts The case for Novavax Novavax earned approval...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
The Motley Fool via AOL· 6 days agoBut it was news about a partnership that gave the shares a clear direction over just the past few...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA Today· 6 hours agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 2 days agovaccine makers say that the Food and Drug Administration’s delay in designing this fall’s Covid-19 ...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 2 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 3 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell? | The Motley Fool
The Motley Fool· 7 days agoNovavax (NVAX -4.30%) took a turn in the investor spotlight in early May, when the vaccine...